Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
Ares Management Corp. Chief Executive Officer Michael Arougheti said he isn’t ruling out more acquisitions for the firm as the race to grow private credit shows little sign of slowing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback